Ken Cacciatore
Stock Analyst at TD Cowen
(0.27)
# 4,048
Out of 4,829 analysts
14
Total ratings
25%
Success rate
-30.5%
Average return
Main Sectors:
Stocks Rated by Ken Cacciatore
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| ARQT Arcutis Biotherapeutics | Maintains: Outperform | $65 → $50 | $14.39 | +247.46% | 2 | Aug 9, 2023 | |
| BHC Bausch Health Companies | Downgrades: Market Perform | n/a | $4.78 | - | 1 | Jun 16, 2023 | |
| TAK Takeda Pharmaceutical Company | Maintains: Outperform | $30 → $20 | $14.19 | +40.94% | 4 | May 16, 2023 | |
| SCPH scPharmaceuticals | Initiates: Outperform | $25 | $2.48 | +908.06% | 1 | Dec 1, 2022 | |
| BLCO Bausch + Lomb | Initiates: Outperform | $35 | $11.89 | +194.37% | 1 | May 11, 2022 | |
| MOLN Molecular Partners AG | Initiates: Outperform | $50 | $4.08 | +1,125.49% | 1 | Jul 13, 2021 | |
| TARA Protara Therapeutics | Initiates: Outperform | $50 | $3.27 | +1,429.05% | 1 | Oct 19, 2020 | |
| BHVN Biohaven | Initiates: Outperform | $45 | $20.56 | +118.87% | 1 | Apr 17, 2020 | |
| AMRN Amarin Corporation | Initiates: Outperform | $460 | $10.42 | +4,314.59% | 1 | Mar 2, 2020 | |
| OPTN OptiNose | Initiates: Outperform | $375 | $9.42 | +3,880.89% | 1 | Dec 18, 2019 |
Arcutis Biotherapeutics
Aug 9, 2023
Maintains: Outperform
Price Target: $65 → $50
Current: $14.39
Upside: +247.46%
Bausch Health Companies
Jun 16, 2023
Downgrades: Market Perform
Price Target: n/a
Current: $4.78
Upside: -
Takeda Pharmaceutical Company
May 16, 2023
Maintains: Outperform
Price Target: $30 → $20
Current: $14.19
Upside: +40.94%
scPharmaceuticals
Dec 1, 2022
Initiates: Outperform
Price Target: $25
Current: $2.48
Upside: +908.06%
Bausch + Lomb
May 11, 2022
Initiates: Outperform
Price Target: $35
Current: $11.89
Upside: +194.37%
Molecular Partners AG
Jul 13, 2021
Initiates: Outperform
Price Target: $50
Current: $4.08
Upside: +1,125.49%
Protara Therapeutics
Oct 19, 2020
Initiates: Outperform
Price Target: $50
Current: $3.27
Upside: +1,429.05%
Biohaven
Apr 17, 2020
Initiates: Outperform
Price Target: $45
Current: $20.56
Upside: +118.87%
Amarin Corporation
Mar 2, 2020
Initiates: Outperform
Price Target: $460
Current: $10.42
Upside: +4,314.59%
OptiNose
Dec 18, 2019
Initiates: Outperform
Price Target: $375
Current: $9.42
Upside: +3,880.89%